The ethical imperative and moral challenges of engaging patients and the public with evidence

Health Affairs

Volumn 35, Issue 4, 2016, Pages 583-589

  Solomon, Mildred Z ^a,b   Gusmano, Michael K ^c   Maschke, Karen J ^a  

^a HASTINGS CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE ORGANIZATION; HUMAN; LEARNING; MORALITY; PARTICIPATORY RESEARCH; PUBLIC HEALTH; WELLBEING; CONFLICT OF INTEREST; ECONOMICS; ETHICS; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HEALTH CARE QUALITY; MALE; PATIENT PARTICIPATION; PUBLIC OPINION; RESOURCE ALLOCATION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

CONFLICT OF INTEREST; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MORAL OBLIGATIONS; PATIENT PARTICIPATION; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PUBLIC HEALTH; PUBLIC OPINION; QUALITY OF HEALTH CARE; RESOURCE ALLOCATION; UNITED STATES;

EID: 84964922636     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2015.1392     Document Type: Article

References (33)

1. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17): 1801-2.
2. Oliver A. Public-sector health-care reforms that work? A case study of the US Veterans Health Administration. Lancet. 2008;371(9619): 1211-3.
3. Peirson L, Ciliska D, Dobbins M, Mowat D. Building capacity for evidence informed decision making in public health: a case study of organizational change. BMC Public Health. 2012;12: 137.
4. Solomon MZ. The ethical urgency of advancing implementation science. Am J Bioeth. 2010;10(8): 31-2.
5. Bonham AC, Solomon MZ. Moving comparative effectiveness research into practice: implementation science and the role of academic medicine. Health Aff (Millwood). 2010;29(10): 1901-5.
6. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manage. 2008;4(1): 269-86.
7. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in healthcare. Washington (DC): National Academies Press;2003.
8. Mazure CM, Jones DP. Twenty years and still counting: including women as participants and studying sex and gender in biomedical research. BMC Womens Health. 2015;15: 94.
9. Grob R. Testing baby: the transformation of newborn screening, parenting, and policy making. New Brunswick (NJ): Rutgers University Press;2011.
10. Gusmano MK. FDA decisions and public deliberation: challenges and opportunities. Public Adm Rev. 2013;73(1): S115-26.
11. Fojo T, Grady C. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst. 2009;101(15): 1044-8.
12. Berlinger N, Jennings B, Wolf SM. The Hastings Center guidelines for decisions on life-sustaining treatment and care near the end of life. Rev. and expanded 2nd ed. Oxford: Oxford University Press;2013.
13. Blinderman CD, Krakauer EL, Solomon MZ. Time to revise the approach to determining cardiopulmonary resuscitation status. JAMA. 2012;37(9): 917-8.
14. Centers for Disease Control and Prevention. Measles cases and outbreaks [Internet]. Atlanta (GA): CDC; [last updated 2016 Feb 10; cited 2016 Feb 11]. Available from: http://www.cdc.gov/measles/cases-outbreaks.html.
15. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103): 637-41. Retraction in Lancet. 2010;375(9713): 445.
16. Institute of Medicine and National Academy of Engineering Roundtable on Value and Science-Driven Health Care. Engineering a learning health-care system: a look at the future: workshop summary. Washington (DC): National Academies Press;2011.
17. Marmor T, Oberlander J. From HMOs to ACOs: the quest for the holy grail in U.S. health policy. J Gen Intern Med 2012;27(9):1215-8.
18. Fishkin JS. The voice of the people: public opinion and democracy. New Haven (CT): Yale University Press;1995.
19. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10): 716-26.
20. Reinhardt UE. The uproar over mammography. New York Times. 2009 Nov 20.
21. Gusmano MK, Gray BH. Evidence and fear: navigating the politics of evidence-based medicine [Internet]. Washington (DC): AcademyHealth; [cited 2016 Feb 11]. Available from: http://www.academyhealth.org/files/publications/academyhealthreports/evidenceandfear.pdf.
22. Truog RD. Screening mammography and the "r" word. N Engl J Med. 2009;361(26): 2501-3.
23. Sekeres MA. The Avastin story. N Engl J Med. 2011;365(15): 1454-5.
24. D'Agostino RB Sr. Changing end points in breast-cancer drug approval-the Avastin story. N Engl J Med. 2011;365(2): e2.
25. National Comprehensive Cancer Network. NCCN guidelines for patients, version 1.2014: stage IV breast cancer [Internet]. Fort Washington (PA): NCCN;2014 [cited 2016 Feb 11]. Available from: http://www.nccn.org/patients/guidelines/stage_iv_breast/index.html#22.
26. Rodwin MA. Rooting out institutional corruption to manage inappropriate off-label drug use. J Law Med Ethics. 2013;41(3): 654-64.
27. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract. 2011;7(3 Suppl):18s-24s.
28. CMS.gov. Decision memo for beta amyloid positron emission tomography in dementia and neurodegenerative disease (CAG-0431N) [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services;2013 Sep 27 [cited 2016 Feb 11] Available from: http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=265.
29. Sorenson C, Gusmano MK, Oliver A. The politics of comparative effectiveness research: lessons from recent history. J Health Polit Policy Law. 2014;39(1): 139-70.
30. Jason LA, Glenwick DS, editors. Handbook of methodological approaches to community-based research: qualitative, quantitative, and mixed methods. New York (NY): Oxford University Press;2016.
31. Largent EA, Miller FG, Joffe S. A prescription for ethical learning. Commentary. Hastings Cent Rep. 2013;(Spec no): S28-9.
32. Solomon MZ, Bonham AC. Ethical oversight of research on patient care. Hastings Cent Rep. 2013;(Spec no): S2-3.
33. Daniels N, Sabin JE. Setting limits fairly: learning to share resources for health. 2nd ed. Oxford: Oxford University Press;2008.